Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph not_applicable
4
67%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Withdrawn1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

completed350%
withdrawn117%
unknown117%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
withdrawnnot_applicable

PermeaDerm® vs. Mepilex-Ag® in Promoting Healing of Partial-thickness Burn Wounds

NCT03613870
completedphase_3

A Trial Comparing a Cellulose Dressing to Two Standard of Care Dressings in Treating Split Thickness Donor Sites in Burn and Wound Patients.

NCT05499104
unknownnot_applicable

Evaluation of the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag®

NCT05084183
terminatednot_applicable

Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.

NCT02765737
completednot_applicable

Mepilex Ag Versus Silver Sulfadiazine in Children and Adults With Burn Injuries.

NCT01439074
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03613870Not Applicable

PermeaDerm® vs. Mepilex-Ag® in Promoting Healing of Partial-thickness Burn Wounds

Withdrawn
NCT05499104Phase 3

A Trial Comparing a Cellulose Dressing to Two Standard of Care Dressings in Treating Split Thickness Donor Sites in Burn and Wound Patients.

Completed
NCT05084183Not Applicable

Evaluation of the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag®

Unknown
NCT02765737Not Applicable

Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.

Terminated
NCT01439074Not Applicable

Mepilex Ag Versus Silver Sulfadiazine in Children and Adults With Burn Injuries.

Completed
NCT01036438Phase 4

Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers

Completed

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6